Concepts (252)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Epilepsy, Temporal Lobe | 9 | 2022 | 138 | 4.140 |
Why?
|
| Connectome | 14 | 2022 | 91 | 3.770 |
Why?
|
| Aphasia | 12 | 2022 | 119 | 3.350 |
Why?
|
| Morals | 6 | 2020 | 27 | 3.090 |
Why?
|
| Executive Function | 20 | 2018 | 106 | 3.060 |
Why?
|
| Frontotemporal Dementia | 14 | 2015 | 17 | 2.590 |
Why?
|
| Cognition Disorders | 18 | 2018 | 342 | 2.370 |
Why?
|
| White Matter | 5 | 2021 | 174 | 2.280 |
Why?
|
| Judgment | 7 | 2016 | 40 | 2.060 |
Why?
|
| Empathy | 6 | 2016 | 45 | 2.040 |
Why?
|
| Neuropsychological Tests | 35 | 2018 | 517 | 2.030 |
Why?
|
| Epilepsy | 6 | 2022 | 336 | 2.020 |
Why?
|
| Decision Making | 7 | 2020 | 410 | 1.760 |
Why?
|
| Drug Resistant Epilepsy | 3 | 2021 | 44 | 1.760 |
Why?
|
| Brain | 16 | 2022 | 2175 | 1.680 |
Why?
|
| Diffusion Tensor Imaging | 10 | 2021 | 211 | 1.610 |
Why?
|
| Speech | 4 | 2021 | 118 | 1.560 |
Why?
|
| Language | 11 | 2022 | 120 | 1.480 |
Why?
|
| Neural Pathways | 9 | 2022 | 323 | 1.330 |
Why?
|
| Cognition | 12 | 2020 | 512 | 1.280 |
Why?
|
| Social Perception | 4 | 2016 | 44 | 1.200 |
Why?
|
| Magnetic Resonance Imaging | 22 | 2022 | 2222 | 1.200 |
Why?
|
| Theory of Mind | 8 | 2016 | 9 | 1.130 |
Why?
|
| Affective Symptoms | 3 | 2016 | 50 | 1.110 |
Why?
|
| Nerve Net | 7 | 2022 | 180 | 1.100 |
Why?
|
| Stroke | 12 | 2022 | 2161 | 1.090 |
Why?
|
| Seizures | 4 | 2022 | 279 | 1.070 |
Why?
|
| Machine Learning | 3 | 2022 | 170 | 1.040 |
Why?
|
| Language Tests | 7 | 2022 | 36 | 0.970 |
Why?
|
| Humans | 87 | 2022 | 68525 | 0.960 |
Why?
|
| Social Behavior | 7 | 2018 | 164 | 0.960 |
Why?
|
| Memory | 7 | 2012 | 214 | 0.940 |
Why?
|
| Axons | 2 | 2021 | 139 | 0.920 |
Why?
|
| Dementia | 5 | 2014 | 158 | 0.910 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 3 | 2015 | 19 | 0.780 |
Why?
|
| Female | 56 | 2022 | 38015 | 0.770 |
Why?
|
| Male | 54 | 2022 | 37281 | 0.700 |
Why?
|
| Neurosurgical Procedures | 1 | 2020 | 98 | 0.700 |
Why?
|
| Middle Aged | 42 | 2022 | 21119 | 0.700 |
Why?
|
| Temporal Lobe | 3 | 2021 | 125 | 0.680 |
Why?
|
| Functional Laterality | 3 | 2017 | 240 | 0.680 |
Why?
|
| Physicians | 2 | 2013 | 324 | 0.650 |
Why?
|
| Brain Mapping | 7 | 2022 | 531 | 0.630 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 2017 | 41 | 0.620 |
Why?
|
| Frontotemporal Lobar Degeneration | 3 | 2011 | 4 | 0.600 |
Why?
|
| Adult | 35 | 2022 | 21375 | 0.600 |
Why?
|
| Thrombocytopenia | 1 | 2017 | 122 | 0.590 |
Why?
|
| Venous Thrombosis | 1 | 2017 | 124 | 0.570 |
Why?
|
| Thrombosis | 1 | 2017 | 218 | 0.560 |
Why?
|
| Punishment | 1 | 2016 | 25 | 0.560 |
Why?
|
| Gray Matter | 4 | 2021 | 57 | 0.550 |
Why?
|
| Quality of Life | 2 | 2022 | 1515 | 0.550 |
Why?
|
| Alzheimer Disease | 7 | 2012 | 563 | 0.540 |
Why?
|
| Aged | 33 | 2022 | 14842 | 0.520 |
Why?
|
| Pattern Recognition, Visual | 1 | 2015 | 69 | 0.510 |
Why?
|
| Anticoagulants | 1 | 2017 | 356 | 0.510 |
Why?
|
| Multiple Sclerosis | 1 | 2016 | 132 | 0.500 |
Why?
|
| Language Disorders | 3 | 2022 | 22 | 0.500 |
Why?
|
| Verbal Learning | 2 | 2011 | 29 | 0.490 |
Why?
|
| Parkinson Disease | 5 | 2018 | 272 | 0.470 |
Why?
|
| Ethical Theory | 1 | 2013 | 4 | 0.460 |
Why?
|
| Analysis of Variance | 11 | 2016 | 1039 | 0.450 |
Why?
|
| Professional Practice | 1 | 2013 | 47 | 0.450 |
Why?
|
| Electroencephalography | 6 | 2022 | 418 | 0.450 |
Why?
|
| Professional Competence | 1 | 2013 | 100 | 0.430 |
Why?
|
| Intelligence | 4 | 2020 | 45 | 0.430 |
Why?
|
| Burnout, Professional | 1 | 2013 | 64 | 0.430 |
Why?
|
| Aphasia, Primary Progressive | 1 | 2012 | 4 | 0.420 |
Why?
|
| Insanity Defense | 1 | 2011 | 11 | 0.410 |
Why?
|
| Concept Formation | 1 | 2011 | 16 | 0.410 |
Why?
|
| Case-Control Studies | 10 | 2021 | 1548 | 0.400 |
Why?
|
| Autistic Disorder | 1 | 2012 | 77 | 0.400 |
Why?
|
| Sex Characteristics | 1 | 2013 | 295 | 0.390 |
Why?
|
| Hippocampus | 4 | 2022 | 471 | 0.380 |
Why?
|
| ROC Curve | 6 | 2020 | 392 | 0.380 |
Why?
|
| Mental Competency | 1 | 2010 | 29 | 0.380 |
Why?
|
| Image Processing, Computer-Assisted | 6 | 2020 | 689 | 0.380 |
Why?
|
| Emotions | 3 | 2020 | 244 | 0.350 |
Why?
|
| Neurodegenerative Diseases | 1 | 2010 | 102 | 0.350 |
Why?
|
| Education, Medical | 1 | 2011 | 147 | 0.350 |
Why?
|
| Hydrocephalus, Normal Pressure | 1 | 2009 | 5 | 0.340 |
Why?
|
| Surveys and Questionnaires | 4 | 2013 | 2798 | 0.330 |
Why?
|
| Aged, 80 and over | 13 | 2019 | 4843 | 0.320 |
Why?
|
| Activities of Daily Living | 1 | 2009 | 319 | 0.310 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 4 | 2014 | 189 | 0.290 |
Why?
|
| Bipolar Disorder | 4 | 2014 | 307 | 0.290 |
Why?
|
| Verbal Behavior | 3 | 2015 | 27 | 0.260 |
Why?
|
| Sclerosis | 2 | 2022 | 32 | 0.260 |
Why?
|
| Young Adult | 7 | 2020 | 5708 | 0.240 |
Why?
|
| Treatment Outcome | 5 | 2021 | 7028 | 0.230 |
Why?
|
| Psychiatric Status Rating Scales | 5 | 2013 | 782 | 0.230 |
Why?
|
| Gambling | 3 | 2013 | 7 | 0.230 |
Why?
|
| Comprehension | 2 | 2015 | 71 | 0.230 |
Why?
|
| Frontal Lobe | 4 | 2019 | 156 | 0.220 |
Why?
|
| Prefrontal Cortex | 3 | 2014 | 639 | 0.220 |
Why?
|
| Epilepsy, Generalized | 1 | 2022 | 15 | 0.220 |
Why?
|
| Broca Area | 1 | 2021 | 5 | 0.210 |
Why?
|
| Support Vector Machine | 1 | 2021 | 15 | 0.200 |
Why?
|
| Carotid Artery, Internal | 2 | 2011 | 85 | 0.200 |
Why?
|
| Neuroimaging | 2 | 2020 | 122 | 0.200 |
Why?
|
| Corpus Callosum | 1 | 2021 | 29 | 0.200 |
Why?
|
| Factor Analysis, Statistical | 2 | 2013 | 201 | 0.190 |
Why?
|
| Parahippocampal Gyrus | 1 | 2020 | 15 | 0.190 |
Why?
|
| Bayes Theorem | 1 | 2022 | 303 | 0.190 |
Why?
|
| Epileptic Syndromes | 1 | 2020 | 3 | 0.190 |
Why?
|
| Human Development | 1 | 2020 | 6 | 0.190 |
Why?
|
| Carotid Stenosis | 2 | 2011 | 163 | 0.180 |
Why?
|
| Speech Production Measurement | 2 | 2019 | 14 | 0.180 |
Why?
|
| Psychomotor Performance | 2 | 2012 | 213 | 0.180 |
Why?
|
| Brain Injuries | 2 | 2015 | 268 | 0.180 |
Why?
|
| Stereotaxic Techniques | 1 | 2019 | 35 | 0.180 |
Why?
|
| Artificial Intelligence | 1 | 2021 | 159 | 0.180 |
Why?
|
| Laser Therapy | 1 | 2019 | 54 | 0.180 |
Why?
|
| Adolescent | 4 | 2022 | 8903 | 0.170 |
Why?
|
| Vision Disorders | 1 | 2019 | 94 | 0.170 |
Why?
|
| Reference Values | 2 | 2018 | 579 | 0.170 |
Why?
|
| Text Messaging | 1 | 2019 | 47 | 0.170 |
Why?
|
| Psychological Tests | 2 | 2016 | 96 | 0.170 |
Why?
|
| Cohort Studies | 4 | 2022 | 2356 | 0.160 |
Why?
|
| Learning | 1 | 2020 | 186 | 0.160 |
Why?
|
| Diagnosis, Differential | 5 | 2019 | 1139 | 0.160 |
Why?
|
| Amygdala | 1 | 2019 | 159 | 0.160 |
Why?
|
| Pipecolic Acids | 1 | 2017 | 9 | 0.160 |
Why?
|
| Brain Ischemia | 2 | 2016 | 665 | 0.160 |
Why?
|
| Healthy Volunteers | 1 | 2018 | 78 | 0.160 |
Why?
|
| Atrophy | 4 | 2022 | 112 | 0.160 |
Why?
|
| Attention | 4 | 2012 | 225 | 0.160 |
Why?
|
| Platelet Count | 1 | 2017 | 100 | 0.160 |
Why?
|
| Models, Neurological | 2 | 2016 | 136 | 0.150 |
Why?
|
| Anxiety Disorders | 1 | 2020 | 426 | 0.150 |
Why?
|
| Walking Speed | 1 | 2017 | 31 | 0.150 |
Why?
|
| Arginine | 1 | 2017 | 102 | 0.150 |
Why?
|
| Educational Status | 1 | 2018 | 273 | 0.150 |
Why?
|
| Cerebral Cortex | 2 | 2010 | 415 | 0.150 |
Why?
|
| Retrospective Studies | 5 | 2022 | 7264 | 0.150 |
Why?
|
| Sulfonamides | 1 | 2017 | 141 | 0.140 |
Why?
|
| Upper Extremity | 1 | 2017 | 112 | 0.140 |
Why?
|
| Evoked Potentials | 2 | 2018 | 61 | 0.140 |
Why?
|
| Neuroanatomy | 1 | 2015 | 14 | 0.130 |
Why?
|
| Motor Cortex | 1 | 2017 | 158 | 0.130 |
Why?
|
| Anomia | 1 | 2015 | 9 | 0.130 |
Why?
|
| Speech Therapy | 1 | 2015 | 19 | 0.130 |
Why?
|
| Consciousness Disorders | 1 | 2015 | 7 | 0.130 |
Why?
|
| Brain Infarction | 1 | 2015 | 54 | 0.130 |
Why?
|
| Regression Analysis | 2 | 2013 | 737 | 0.120 |
Why?
|
| Personality Disorders | 1 | 2014 | 43 | 0.120 |
Why?
|
| Memory, Short-Term | 2 | 2011 | 79 | 0.120 |
Why?
|
| Nervous System Diseases | 1 | 2015 | 142 | 0.120 |
Why?
|
| Disability Evaluation | 1 | 2016 | 298 | 0.120 |
Why?
|
| Disease Progression | 3 | 2015 | 1037 | 0.120 |
Why?
|
| Reproducibility of Results | 4 | 2015 | 2077 | 0.120 |
Why?
|
| Severity of Illness Index | 2 | 2016 | 1851 | 0.120 |
Why?
|
| Knowledge | 1 | 2013 | 18 | 0.120 |
Why?
|
| Spain | 2 | 2011 | 34 | 0.120 |
Why?
|
| Schizophrenia | 2 | 2013 | 206 | 0.120 |
Why?
|
| Principal Component Analysis | 1 | 2013 | 55 | 0.110 |
Why?
|
| Psychometrics | 3 | 2012 | 514 | 0.110 |
Why?
|
| Altruism | 1 | 2013 | 24 | 0.110 |
Why?
|
| Religion | 1 | 2013 | 23 | 0.110 |
Why?
|
| Problem Solving | 2 | 2011 | 36 | 0.110 |
Why?
|
| Asperger Syndrome | 1 | 2012 | 7 | 0.110 |
Why?
|
| Area Under Curve | 2 | 2010 | 238 | 0.110 |
Why?
|
| Dementia, Vascular | 1 | 2012 | 22 | 0.110 |
Why?
|
| Databases, Factual | 1 | 2015 | 621 | 0.110 |
Why?
|
| Demography | 1 | 2013 | 279 | 0.110 |
Why?
|
| Cerebellum | 1 | 2013 | 103 | 0.100 |
Why?
|
| Intention | 1 | 2012 | 78 | 0.100 |
Why?
|
| Postoperative Complications | 1 | 2019 | 1615 | 0.100 |
Why?
|
| Latin America | 1 | 2011 | 19 | 0.100 |
Why?
|
| Schizophrenic Psychology | 1 | 2011 | 53 | 0.100 |
Why?
|
| Face | 1 | 2011 | 46 | 0.100 |
Why?
|
| Mental Recall | 1 | 2011 | 72 | 0.100 |
Why?
|
| Huntington Disease | 1 | 2010 | 15 | 0.100 |
Why?
|
| Statistics as Topic | 1 | 2011 | 219 | 0.100 |
Why?
|
| Angioplasty | 1 | 2011 | 118 | 0.090 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2011 | 257 | 0.090 |
Why?
|
| Criminals | 1 | 2010 | 26 | 0.090 |
Why?
|
| Mental Processes | 1 | 2010 | 22 | 0.090 |
Why?
|
| Acoustic Stimulation | 1 | 2011 | 206 | 0.090 |
Why?
|
| Causality | 1 | 2010 | 81 | 0.090 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 3 | 2020 | 239 | 0.090 |
Why?
|
| Neurology | 1 | 2010 | 43 | 0.090 |
Why?
|
| Awareness | 1 | 2010 | 81 | 0.090 |
Why?
|
| Automobile Driving | 1 | 2010 | 88 | 0.090 |
Why?
|
| Brain Diseases | 1 | 2010 | 78 | 0.090 |
Why?
|
| Family | 1 | 2011 | 293 | 0.090 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2009 | 16 | 0.090 |
Why?
|
| Perception | 1 | 2010 | 189 | 0.080 |
Why?
|
| Observer Variation | 1 | 2009 | 330 | 0.080 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 3256 | 0.080 |
Why?
|
| Chronic Disease | 3 | 2018 | 1329 | 0.080 |
Why?
|
| Sensitivity and Specificity | 4 | 2015 | 1753 | 0.080 |
Why?
|
| Necrosis | 2 | 2018 | 239 | 0.080 |
Why?
|
| Discriminant Analysis | 2 | 2019 | 36 | 0.070 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2020 | 237 | 0.070 |
Why?
|
| Photic Stimulation | 2 | 2019 | 229 | 0.060 |
Why?
|
| Linear Models | 2 | 2017 | 521 | 0.060 |
Why?
|
| Cross-Sectional Studies | 2 | 2022 | 2264 | 0.060 |
Why?
|
| Alcohol Drinking | 1 | 2010 | 805 | 0.060 |
Why?
|
| Animals | 3 | 2015 | 20877 | 0.060 |
Why?
|
| Semantics | 1 | 2022 | 37 | 0.050 |
Why?
|
| Immunoglobulin E | 1 | 2022 | 91 | 0.050 |
Why?
|
| Argentina | 2 | 2011 | 9 | 0.050 |
Why?
|
| Substance-Related Disorders | 1 | 2010 | 1241 | 0.050 |
Why?
|
| Psychosurgery | 1 | 2019 | 9 | 0.050 |
Why?
|
| Statistics, Nonparametric | 2 | 2010 | 306 | 0.050 |
Why?
|
| Visual Fields | 1 | 2019 | 41 | 0.040 |
Why?
|
| Gene Expression | 1 | 2022 | 770 | 0.040 |
Why?
|
| Mental Status and Dementia Tests | 1 | 2018 | 9 | 0.040 |
Why?
|
| Cell Count | 1 | 2018 | 248 | 0.040 |
Why?
|
| Early Diagnosis | 1 | 2018 | 122 | 0.040 |
Why?
|
| Neurologic Examination | 1 | 2017 | 107 | 0.040 |
Why?
|
| Risk Factors | 2 | 2019 | 5719 | 0.040 |
Why?
|
| Biomarkers | 1 | 2022 | 1593 | 0.040 |
Why?
|
| Mental Disorders | 2 | 2013 | 659 | 0.030 |
Why?
|
| Amnesia | 1 | 2015 | 17 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2012 | 3702 | 0.030 |
Why?
|
| Personality Inventory | 1 | 2014 | 196 | 0.030 |
Why?
|
| Infant | 1 | 2020 | 2891 | 0.030 |
Why?
|
| Trail Making Test | 1 | 2013 | 7 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2020 | 3185 | 0.030 |
Why?
|
| Age Factors | 1 | 2018 | 1860 | 0.030 |
Why?
|
| Mental Status Schedule | 1 | 2012 | 31 | 0.030 |
Why?
|
| Age of Onset | 1 | 2013 | 188 | 0.030 |
Why?
|
| Peru | 1 | 2012 | 11 | 0.030 |
Why?
|
| Affect | 1 | 2014 | 218 | 0.030 |
Why?
|
| Space Perception | 1 | 2012 | 44 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2016 | 1465 | 0.030 |
Why?
|
| Social Environment | 1 | 2013 | 182 | 0.030 |
Why?
|
| Ischemia | 1 | 2012 | 229 | 0.020 |
Why?
|
| Family Health | 1 | 2011 | 83 | 0.020 |
Why?
|
| Interpersonal Relations | 1 | 2012 | 209 | 0.020 |
Why?
|
| Reaction Time | 1 | 2011 | 170 | 0.020 |
Why?
|
| Levodopa | 1 | 2010 | 12 | 0.020 |
Why?
|
| Matched-Pair Analysis | 1 | 2010 | 25 | 0.020 |
Why?
|
| Pick Disease of the Brain | 1 | 2010 | 3 | 0.020 |
Why?
|
| Caregivers | 1 | 2014 | 365 | 0.020 |
Why?
|
| Antiparkinson Agents | 1 | 2010 | 34 | 0.020 |
Why?
|
| Personality Assessment | 1 | 2010 | 71 | 0.020 |
Why?
|
| Brain Damage, Chronic | 1 | 2010 | 25 | 0.020 |
Why?
|
| Germany | 1 | 2010 | 67 | 0.020 |
Why?
|
| Consciousness | 1 | 2010 | 17 | 0.020 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2010 | 137 | 0.020 |
Why?
|
| History, 20th Century | 1 | 2010 | 248 | 0.020 |
Why?
|
| Aging | 1 | 2015 | 911 | 0.020 |
Why?
|
| Choice Behavior | 1 | 2009 | 85 | 0.020 |
Why?
|
| Depressive Disorder, Major | 1 | 2013 | 438 | 0.020 |
Why?
|
| Recurrence | 1 | 2010 | 948 | 0.020 |
Why?
|
| Stents | 1 | 2011 | 657 | 0.020 |
Why?
|
| Pain | 1 | 2010 | 472 | 0.020 |
Why?
|
| Hypertension | 1 | 2015 | 1531 | 0.020 |
Why?
|
| Time Factors | 1 | 2010 | 4655 | 0.010 |
Why?
|